These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Risk of adverse events with fibrates.
    Author: Alsheikh-Ali AA, Kuvin JT, Karas RH.
    Journal: Am J Cardiol; 2004 Oct 01; 94(7):935-8. PubMed ID: 15464682.
    Abstract:
    An increased risk for adverse events was observed with gemfibrozil relative to fenofibrate, predominantly driven by an increased rate of rhabdomyolysis. This difference was especially noticeable in patients taking the combination of gemfibrozil and a statin, particularly cerivastatin.
    [Abstract] [Full Text] [Related] [New Search]